KEY FINDINGS The Asia-Pacific hyperphosphatemia drugs market was worth $xx million in 2018. The market is estimated to grow at a CAGR of 17.37% during the forecast period of 2019-2027 and generate $xx million by the end of 2027. Diabetes and hypertension are the main causes of renal failure, which in turn leads to hyperphosphatemia. The growing prevalence of such chronic diseases, increasing elderly population, unmet medical attention, and the rise in public awareness are the major drivers for the hyperphosphatemia drugs market in this region. The Asia-Pacific regions are expected to further propel the growth of the market in the coming years.
MARKET INSIGHTS Increased cases of osteoporosis in the ageing population are observed in the Asia-Pacific regions, which are mostly going undertreated and underdiagnosed.This lapse is majorly responsible for the demand of the hyperphosphatemia drugs market in the Asian countries.
The Indian hyperphosphatemia drugs market is growing with the highest CAGR of xx% during the forecast period.Growing elderly population in India is the key driving factor responsible for increasing the demand of the hyperphosphatemia drugs market in this region.
The hyperphosphatemia drug market is segmented on the basis of the drug formulation.They include iron-based phosphate binders, calcium-based phosphate binders, magnesium-based phosphate binders, aluminium-based phosphate binders, and other phosphate binders.
The Calcium-based phosphate binder’s formulation is expected to lead the hyperphosphatemia drugs market during the forecast years. The Aluminium-based phosphate binders generated a revenue of $xx million in 2018 and are widely being used for the treatment of hyperphosphatemia in dialysis patients. The magnesium-based phosphorus binders are another widely used phosphorus binders, which also are remarkably being engaged in curing the hyperphosphatemia conditions in all the dialysis patients.
COMPETITIVE INSIGHTS The major players in the hyperphosphatemia drug market are Johnson And Johnson, Cipla, Dsm, Biotech Pharmacal, Sun Pharm Inc, Zeria Pharmaceutical, Ultragenyx, Bruno Farmaceutici Spa, Fermenta Biotech Ltd, Fresenius Medical Care Pfizer Inc, Roche Diagnostics Corporation, Keryx Biopharmaceuticals , R.H. Moore Drug Co, Vifor Pharma, Sanofi, and Amag Pharmaceuticals.
Companies mentioned 1. AMAG PHARMACEUTICALS 2. BIOTECH PHARMACAL 3. BRUNO FARMACEUTICI SPA 4. CIPLA 5. FERMENTA BIOTECH LTD. 6. FRESENIUS MEDICAL CARE 7. JOHNSON AND JOHNSON 8. KERYX BIOPHARMACEUTICALS INC. 9. PFIZER INC. 10. ROCHE DIAGNOSTICS CORPORATION 11. ROYAL DSM N.V. 12. SANOFI 13. SHIRE 14. SUN PHARMACEUTICAL INDUSTRIES LTD. 15. ULTRAGENYX PHARMACEUTICAL INC. 16. ZERIA PHARMACEUTICAL
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• Apr 2021
Major players in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market are Abbott Laboratories, Agilent Technologies Inc., Biomerieux Sa, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd (Roche Diagnostics), Qiagen N.V., Genmark Diagnostics, Thermo Fisher Scientific Inc., General Electric Company (Ge...
Wound Care Market Size, Share & Trends Analysis Report By Application (Chronic, Acute Wounds), By Product (Advanced, Surgical), By End Use (Hospitals, Home Healthcare), By Region, And Segment Forecasts, 2021 - 2028
Wound Care Market Growth & Trends
The global wound care market size is expected to reach USD...
Biopreservation refers to the process of preserving cells, tissues or organs outside of their native environment for extended period of time. It has emerged as an effective preservation technique for long-term storage. Owing to this, biopreservation has become vital for the success of various clinical and commercial...
Global Glycobiology Market, By Product (Enzymes, Instruments, Reagents and Kits), By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others), By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others), By Region, Competition,...
Trends, opportunities and forecast in medical lifting sling market to 2026 by product type (spectacles, contact lenses, and sunglasses), distribution channel (offline and online), gender (men and women), and region (North America, Europe, Asia Pacific, and the Rest of the World) The future of the medical lifting sling market looks promising...
KEY FINDINGS The global digital genome market is set to record a CAGR of 9.43% during the forecast period, 2021-2028. The rising investment in genomics by governments and manufacturers, the increasing prevalence of chronic diseases, and technological advancements, are projected to propel the market growth. MARKET...
Blood Purification Equipment Market by Product Type(Portable and Stationary), Indication (Sepsis, Renal Diseases, and Others) and End User (Hospitals and Clinics, Dialysis Centers and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027
Blood purification allows removal of toxic or pathogenic substances...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the biosimilar therapeutic peptides market are Eli Lilly, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc., Amgen Inc., AstraZeneca PLC, GlaxoSmithKline (GSK), Novartis AG and Novo Nordisk A/S. The global biosimilar therapeutic peptides market is expected to decline from $0.80 billion in 2019 to $0.77...
Chronic Kidney Disease-Anemia - Epidemiology Forecast to 2029
Chronic kidney disease (CKD) is a condition characterized by a gradual loss of kidney function over time.Anemia is a frequent complication of CKD.
By definition, anemia refers to an absolute reduction of the total number...
Report Scope: Medication adherence systems include hardware-based systems (e.g., smart pill bottles, smart caps, automated pill dispensers, electronic trays, smart medical watches, smart medical alarms, wearable sensors and other packaging systems) and software-based internet applications (e.g., cloud-based databases, health...
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.